Stockreport

AbCellera Biologics GAAP EPS of -$0.19 misses by $0.02, revenue of $8.96M beats by $2.63M [Seeking Alpha]

AbCellera Biologics Inc. - Common Shares  (ABCL) 
PDF More on AbCellera Biologics AbCellera Biologics: Entering Growth Phase After A Pause AbCellera: Shares Have Momentum, But Does The Pipeline? It's Too Early To Tell [Read more]